BriefCase vs Clinical Deterioration Index (CDI)

BriefCase offers a mobile app for both iOS and Android, enabling care teams to collaborate and access critical findings on the go. It also integrates seamlessly with existing PACS, RIS, and EHR systems, suggesting a user-friendly experience within established clinical workflows. While CDI integrates with Epic EHR, it doesn't explicitly mention a dedicated mobile app or broad integration capabilities beyond Epic.

BriefCase is FDA-cleared for numerous indications, including various intracranial hemorrhages, pulmonary embolisms, and aortic dissections, demonstrating a broad scope of validated clinical utility. It has also been validated through over 230 published studies and abstracts. CDI, while reporting an 18.6% reduction in mortality and integration with Epic EHR for early patient decline detection, does not have FDA clearance and has fewer publicly available validation studies.

BriefCase has enterprise pricing starting at approximately $50,000 per site per year, with additional costs per module, which can be an affordability barrier for smaller institutions. CDI's pricing is not publicly available, making a direct comparison difficult. Neither tool offers transparent, publicly listed pricing, which makes assessing overall value challenging for potential customers.

BriefCase is designed for large hospitals and health systems, has over 500 global customers, and offers comprehensive compliance (HIPAA, SOC2, GDPR, BAA) and API availability. CDI is integrated within the Epic EHR platform, which suggests readiness for Epic-centric enterprises, but lacks explicit details on broader compliance, customer count, or API availability.

BriefCase leverages Aidoc's proprietary aiOSu2122 and CAREu2122 Foundation Model, offering a comprehensive AI triage solution with a focus on reducing false alerts and expanding to all CT and X-ray workflows. It also offers automated draft report creation capabilities. CDI utilizes a predictive AI algorithm for early patient decline detection within EMR data, which is valuable but appears to be a more focused application compared to Aidoc's broader platform approach and future roadmap.

BriefCase, as a commercial product from Aidoc, likely offers structured customer support and documentation, including user guides and clinical compendiums, given its widespread adoption and FDA clearances. CDI, being developed by a health system and university, may have support primarily tailored to its internal users and Epic integration, with less emphasis on external-facing documentation or dedicated support channels for other organizations.